Remala Abadi Tbk. vs Millennium Pharmacon International Tbk. — how do they compare? Remala Abadi Tbk. trades at Rp2,450 (market cap 3.29T, 15.47M 24h volume), while Millennium Pharmacon International Tbk. trades at Rp181 (market cap 230.59B, 12.1K 24h volume). The key difference: Remala Abadi Tbk. is far larger — about 14.3× Millennium Pharmacon International Tbk.'s market cap, and Remala Abadi Tbk. is more actively traded (15.47M versus 12.1K). Which is the better fit depends on your goals.
| DATA | SDPC | |
|---|---|---|
Market Cap | 3.29T | 230.59B |
Volume | 15.47M | 12.1K |
Lot | 154.74K | 121 |
Turnover | 37.99B | 2.2M |
Average Price | 2,454.89 | 181.48 |
Value | 37.99B | 2.2M |
Indicative Equilibrium Price | 2,450 | — |
Indicative Equilibrium Volume | 2.17K | — |
Trailing returns across standard periods
Latest headlines on both assets
PT. Remala Abadi Tbk (the Company) was established based on Deed No.5, dated March 15, 2004 made before Notary Fajra Rizqi Nasution, SH. The company started its commercial activities since 2004.
Read more on DATA →PT Millennium Pharmacon International Tbk (the Company) was established on October 20th, 1952 under the name N.V. Perusahaan Dagang SOEDARPO CORPORATION. On July 29th, 1997, the Extraordinary Shareholders meeting held by the Company has approved the sale of assets and of the whole share participation on the Company in PT Praweda Ciptakarsa Informatika and PT Sumber Daya Praweda Informatika. In order to strengthen its equity and settle the foreign currently loan, the Company has conducted its first Right Issue and has submitted the registration statement on May 8th, 2000 to the Capital Advisory Board (BAPEPAM). The Company started its operations on October 20, 1952. The name was changed from previous name PT NVPD Soedarpo Corporation.
Read more on SDPC →